Symplicity China Study
NCT07081243 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2025-11-17
Summary
The Symplicity China study will evaluate the real-world long-term safety, efficacy, and durability of the Symplicity Spyral system in a population of approximately 500 renal denervation treated subjects with up to 36 months of follow up.
Conditions
- Resistant Hypertension
Interventions
- DEVICE
-
Symplicity Spyral Renal Denervation System
Symplicity Renal Denervation
Sponsors & Collaborators
-
Medtronic Vascular
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-11-11
- Primary Completion
- 2028-06-30
- Completion
- 2031-12-30
- FDA Device
- Yes
Countries
- China
Study Locations
More Related Trials
-
Transcatheter Renal Artery Sympathetic Denervation Observational Study
NCT05744986 ·Status: UNKNOWN
-
Renal Denervation in Patients With Uncontrolled Hypertension (Symplicity HTN-2)
NCT00888433 ·Status: COMPLETED ·Phase: NA
-
Sympathetic Mapping/ Ablation of Renal Nerves Trial
NCT02761811 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
SPYRAL HTN-ON MED Study of Renal Denervation With the Symplicity Spyral™ Multi-electrode Renal Denervation System
NCT02439775 ·Status: COMPLETED ·Phase: NA
-
SMART Study in Real World
NCT06780696 ·Status: NOT_YET_RECRUITING
-
Renal Denervation With Sterile Irrigated Deflectable Ablation Catheter Used in Renal Artery in Primary Hypertension
NCT03511313 ·Status: UNKNOWN ·Phase: NA
-
Renal Sympathetic Denervation in Patients With Chronic Kidney Disease and Resistant Hypertension
NCT01737138 ·Status: UNKNOWN ·Phase: NA
-
Renal Sympathetic Denervation in Patients With Drug-resistant Hypertension and Symptomatic Atrial Fibrillation
NCT01713270 ·Status: UNKNOWN ·Phase: NA
-
Renal Denervation in Patients With Refractory Hypertension
NCT00664638 ·Status: COMPLETED ·Phase: NA
-
SPYRAL PIVOTAL - SPYRAL HTN-OFF MED Study
NCT02439749 ·Status: COMPLETED ·Phase: NA
-
Sympathetic Mapping/ Ablation of Renal Nerves Trial (SMART) HTN-OFF MED Study
NCT03885843 ·Status: UNKNOWN ·Phase: NA
-
Renal Denervation in Refractory Hypertension
NCT01560312 ·Status: TERMINATED ·Phase: PHASE3
-
Rapid Renal Sympathetic Denervation for Resistant Hypertension II
NCT01939392 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
Renal Sympathetic Denervation in Mild Refractory Hypertension
NCT01656096 ·Status: COMPLETED ·Phase: PHASE4
-
Renal Denervation in Hypertension
NCT01570777 ·Status: COMPLETED ·Phase: PHASE4
-
Renal Denervation in Patients With Refractory Hypertension
NCT00753285 ·Status: COMPLETED ·Phase: NA
-
Global SYMPLICITY Registry (GSR) DEFINE
NCT01534299 ·Status: RECRUITING
-
Renal Sympathetic Denervation as a New Treatment for Therapy Resistant Hypertension
NCT01850901 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Catheter Based Renal Denervation Therapy in Hypertension
NCT01522430 ·Status: UNKNOWN ·Phase: PHASE3
-
Renal Sympathetic Denervation From the Adventitia on Resistant Hypertension（RSDARH）
NCT03758196 ·Status: UNKNOWN ·Phase: NA
-
Full Length Versus Proximal Renal Arteries Ablation
NCT01848275 ·Status: COMPLETED ·Phase: NA
-
Effects of Renal Sympathetic Denervation on the Cardiac and Renal Functions in Patients With Drug-resistant Hypertension Through MRI Evaluation
NCT02164435 ·Status: UNKNOWN ·Phase: NA
-
"Real-world Assessment of BP Control in Patients With Hypertension by the Netrod RDN System" - REACH-RDN
NCT07273877 ·Status: ENROLLING_BY_INVITATION
-
Renal Denervation for the Treatment of Hypertension: A Pilot Safety and Efficacy Study
NCT02672462 ·Status: UNKNOWN ·Phase: NA
-
Chemical Renal Ethanol Sympatholysis Under CT Guidance Use for the Control of Therapy-Resistant Hypertension
NCT02653222 ·Status: TERMINATED ·Phase: PHASE2